Recalled infant formula

CDC and FDA are concerned that other lots of ByHeart Whole Nutrition infant formula may be contaminated and are making infants sick with infant botulism. Parents and caregivers have reported feeding infants in this outbreak different lots of ByHeart infant formula that were not included in the company’s recall on November 8, 2025. On November 11, 2025, ByHeart Inc. recalled all ByHeart Whole Nutrition infant formula products.

Parents and caregivers are urged to stop using any ByHeart Whole Nutrition infant formula immediately. This includes:

  • All lot numbers
  • All sizes of cans and single serve packets

ByHeart Whole Nutrition Infant Formula is available for sale online and at major retailers nationwide.

What you should do

  • Do not use any ByHeart Whole Nutrition infant formula. This includes formula sold in cans and single serve packets.
    • If possible, take a picture or record the lot number and best by date.
    • If you have leftover ByHeart powdered formula, label it “DO NOT USE” and keep it stored in a safe place for at least a month.
    • If your infant develops symptoms of infant botulism, your state health department may want to collect it for testing. If no symptoms appear after a month, throw the leftover formula away.
  • Seek immediate medical care if your infant has consumed ByHeart Whole Nutrition Infant Formula and has any of these symptoms:
    • Poor feeding
    • Loss of head control
    • Difficulty swallowing
    • Decreased facial expression
  • Symptoms of infant botulism can take as long as several weeks to develop, so parents should remain vigilant if they used ByHeart Whole Nutrition infant formula.

What businesses should do

  • Do not sell or use recalled ByHeart Whole Nutrition infant formula.
  • Wash and sanitize items and surfaces that may have touched recalled formula.

What clinicians should do

  • Initial diagnosis of infant botulism is based on clinical symptoms.
  • Consultation with the Infant Botulism Treatment and Prevention Program
  • If clinical consultation supports infant botulism, begin treatment as soon as possible. Do not wait for laboratory confirmation.
  • Infant botulism is a notifiable disease. All suspected cases must be reported to the state public health department.

Symptoms

  • Most infants with infant botulism will initially develop constipation, poor feeding, loss of head control, and difficulty swallowing.
  • If untreated, infants with infant botulism experience a progressive, flaccid paralysis that can lead to breathing difficulties and require weeks of hospitalization.
  • Treatment with BabyBIG® is recommended for all suspected cases of infant botulism.



Content Source:

National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)